Abstract
Intro: New onset movement disorders are being reported following infection with the SARS-CoV-2 virus. These include myoclonus, tremor, oculomotor disorders, ataxia, akinetic rigid syndrome, catatonia, dystonia, and chorea. IVIG and steroids are shown to improve these neurological manifestations. Narrative: We present a case of a 74-year-old female with multiple comorbidities who developed opsoclonus, upper extremity dystonia, and encephalopathy following infection with COVID-19. Discussion: Currently, no cases have been reported on the combination of dystonia, opsoclonus, and encephalopathy in the presence of COVID-19. Due to the patient's minimal improvement following treatment, more research will need to be done on this topic to tailor pharmacotherapy for the neurological manifestations of this virus. Conclusion: Diagnosing movement disorders following infection with COVID-19 remains controversial. This case highlights the complexity of ruling out other etiologies that could lead to these neurological symptoms and the importance of comprehensive patient care and symptom management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
